Status:

NOT_YET_RECRUITING

Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Base-of-thumb Osteoarthritis

Osteoarthritis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The main objective of this study will be to compare the effects of 2 intra-articular injections of onabotulinumtoxinA with those of 1 intra-articular injection of onabotulinumtoxinA and 1 of normal sa...

Detailed Description

The base of the thumb is a frequent location of osteoarthritis. Base-of-thumb osteoarthritis affects middle-aged and older individuals and results in base-of-thumb pain and limitations in hand-specifi...

Eligibility Criteria

Inclusion

  • • Individuals aged at least 18 years;
  • Pain intensity of at least 30 on a self-administered 11-point pain numeric rating scale (0: no pain to 100: maximal pain);
  • Pain involving the base of the thumb;
  • X-ray evidence of trapezometacarpial osteoarthritis with at least two of the following items involving the trapezometacarpial joint: osteophytes, joint space narrowing, subchondral bone sclerosis, or subchondral cysts;
  • 1990 ACR classification criteria for hand osteoarthritis adapted to trapezometacarpial osteoarthritis.
  • Patient able to give written informed consent prior to participation in the study
  • Affiliation with a mode of social security (profit or being entitled).
  • Negative pregnancy test in women of childbearing potential

Exclusion

  • • Secondary osteoarthritis;
  • History of thumb surgery, inflammatory or crystal-associated rheumatic disease, or epilepsy;
  • Uncontrolled dysphagia, pneumonia, cardiovascular diseases, or clinical or subclinical signs of neuromuscular transmission disorders;
  • Contra-indication to onabotulinumtoxinA;
  • Neurological disorders involving the hands other than carpal tunnel syndrome;
  • Collagen disorders involving the hands;
  • Osteoarthritis predominating at the scaphotrapezial joint on x-ray;
  • Bilateral trapezometacarpial osteoarthritis without a predominant painful side;
  • Hand or wrist trauma for up to 2 months;
  • Intra-articular treatments for up to 2 months;
  • Use of IM, IV or oral corticosteroids for up to 2 months.
  • Protected adults (including individual under guardianship by court order)
  • Pregnant women and lactation; lack of contraception for women of childbearing potential
  • Patient participating in another investigational therapeutic study
  • Patient unable to speak and read french

Key Trial Info

Start Date :

May 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2028

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06902805

Start Date

May 1 2025

End Date

May 1 2028

Last Update

April 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique - Hôpitaux de Paris, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis du Pr François Rannou, Hôpital Cochin

Paris, Île-de-France Region, France, 75014